Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Jul 29, 2026 · 10-Q · 29 days after period end · 0001437749-26-024752
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$8.60M | -$44.22M | $6.16M | -$26.38M |
| EPS Diluted | — | -$0.92 | $0.13 | -$0.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Jul 29, 2026 · 29 d after period end
